Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso

Background. A group A meningococcal (MenA) conjugate vaccine, PsA-TT (MenAfriVac), was introduced in Burkina Faso via mass campaigns between September and December 2010, targeting the 1- to 29-year-old population. This study describes specific antibody titers in the general population 11 months late...

Descripción completa

Detalles Bibliográficos
Autores principales: Tall, Haoua, Yaro, Seydou, Kpoda, Hervé B. N., Ouangraoua, Soumeya, Trotter, Caroline L., Njanpop Lafourcade, Berthe-Marie, Findlow, Helen, Bai, Xilian, Martin, Catherine, Nwakamma, Ikenna, Ouedraogo, Jean Bosco, Gessner, Bradford D., Borrow, Ray, Mueller, Judith E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639492/
https://www.ncbi.nlm.nih.gov/pubmed/26553686
http://dx.doi.org/10.1093/cid/civ519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639492/
https://www.ncbi.nlm.nih.gov/pubmed/26553686
http://dx.doi.org/10.1093/cid/civ519

Ejemplares similares